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Purpose. The purpose of this study was to analyze the safety and feasibility of laparoscopic intersphincteric resection (ISR)
combined with transanal rectal dissection (TARD) for T3 low rectal cancer in a narrow pelvis. Methods. We studied 20 patients
with a narrow pelvis of median body mass index 25.3 (16.9–31.2). Median observation period was 23.6 months (range 12.2–
56.7). Results. Partial, subtotal, and total ISR was performed in 15, 1, and 4 patients, respectively. Median duration of TARD was
83min(range43–135).Therewerenomajorcomplicationsperioperativelyorpostoperatively.Surgicalmarginswerehistologically
free of tumor cells in all patients, and there was no local recurrence. Excluding urgency, frequency of bowel movements, and
incontinence status improved gradually after stoma closure. Conclusion. Laparoscopic ISR combined with TARD is technically
feasible for selective T3 low rectal cancer in patients with a narrow pelvis.
1.Introduction
Intersphincteric resection (ISR) to preserve anal sphincter
function for low rectal cancer extending into the anal canal
was reported by Schiessel et al. in 1994 [1]. The feasibility
of ISR has been demonstrated by surgeons since that time;
it is now technically possible to use ISR to remove low
rectal cancer with preservation of anal sphincter function
with a satisfactory oncologic outcome [2, 3]. Recently, the
clinical outcome of ISR as a laparoscopic approach (laparo-
scopic ISR) has been reported, but laparoscopic ISR for
patients with bulky low rectal cancer remains challenging.
Particularly for T3 tumors in patients with a narrow pelvis,
it is important to achieve a low local recurrence. Total
mesorectal excision (TME), negative circumferential margin
(CFM), and tumor free surgical margin are prerequisites
regardless of approach of ISR. Conversion to open operation
in laparoscopic ISR may inﬂuence prognosis, as is the case
in laparoscopic surgery for rectal cancer [4]. We have shown
that transanal rectal dissection (TARD) performed prior to
the abdominal phase of the operation is very useful for
an adequate oncologic resection in laparoscopic ISR for T3
low rectal cancer in patients with a narrow pelvis [5]. The
purpose of this report is to evaluate the safety and feasibility
ofTARDtoachievelaparoscopicISRforT3lowrectalcancers
in patients with a narrow pelvis.
2. Patients
Preoperative staging evaluation included digital rectal exam-
ination, barium enema, colonoﬁberscope with biopsy, com-
puted tomography (CT), magnetic resonance imaging
(MRI), and transanal ultrasound (TAUS). The patients were
excluded when preoperative examination showed the follow-
ing ﬁndings: multiple metastases in distant organs, direct
invasion into adjacent organs (clinical T4), involvement of2 International Journal of Surgical Oncology
lateral lymph nodes, and invasion into the external anal
sphincter or/and levator ani. We studied 20 patients (5
women, 15 men) with a median age of 66 years (range 42–
77 years) between April 2006 and December 2009. In all
patients the tumors were bulky in nature, and narrow pelvic
dimensionswereexpectedforlaparoscopicallyassistedpelvic
ﬂoor dissection on the basis of radiographic ﬁndings of bar-
ium enema, CT, and MRI. Preoperative CRT was performed
in 2 men out of the 20 patients. Finally, preoperative TNM
s t a g i n go ft h e2 0p a t i e n t sw a sT 3N 0M 0i n8 ,T 3N 1M 0i n
9, T3 N2 M0 in 2, and T3 N3 M1 in one. Median body mass
index was 25.3kg/m2 (range 16.9–31.2kg/m2)( Table 1). The
patients were observed for a median of 23.6 months (range
12.2–56.7 months).
3.SurgicalTechnique
Surgical technique regarding TARD has been described pre-
viously [5]. The operation is performed in the Lloyd-Davies
position. Prior to the laparoscopically assisted abdominal
phase, the anal portion of the operation is initiated. First,
TAUSisperformedtoconﬁrmthedepthofinvasion.IfTAUS
shows tumor invasion to the external sphincter and/or the
levator ani, an abdominoperineal resection (APR) should be
chosen as the surgical procedure. The anal canal is exposed
with a self-holding retractor (Lone Star Retractor, Lone
Star Medical Products Inc., Houston, TX, USA). The distal
side at the lower margin of the tumor is then closed with
purse-string sutures under direct visualization, followed by
irrigation of the anal canal with 5% povidone-iodine. This
step is important for preventing cancer cell dissemination in
the surgical ﬁeld. The division of the rectum is then initiated
posteriorly at least 2cm distal to the tumor margin. A circu-
lar incision of the rectum is performed by closing the cut end
of the rectum with an interrupted suture, and mobilization
of the rectum, including the tumor, is continued proximally
by exposing the levator ani. Invasion of tumor cells on the
dissectedplane(theexternalsphincteror/andthelevatorani)
should be evaluated by microscopic examination of a frozen-
section specimen histologically whenever mobilization of
the rectum is not easy. If any ﬁndings of tumor invasion
into the dissected plane are found, the procedure should
be immediately converted to abdominoperineal resection
(APR). Division and mobilization of the rectum, including
the mesorectum, is performed until the peritoneal reﬂection
on the anterior side, and up until the sacral promontory
beyond the rectosacral ligament, is nearly reached poste-
riorly. Finally, a Lap disc mini (HAKKO Group, Japan) is
adaptedtotheanalcanaltomaintainpressureduringlaparo-
scopy (Figure 1).
Regarding the laparoscopic procedure, a camera port is
inserted in the paraumbilical zone with a trocar, and an
operative port in the mid-lower abdominal region, and two
additional operative ports in the left and right Mc Burney’s
point are inserted. On routine intra-abdominal exploration,
the gauze that is placed on the dissected plane as a landmark
can be identiﬁed through the peritoneum on the anterior
side of the rectum. The sigmoid and descending colon are
mobilized completely from the subretroperitoneal fascia to
Table 1: Characteristics of patients.
Parameter N = 20
Median age 66 (42–77)
Gender: male/female 15/5
Median body mass index (kg/m2) 25.3 (16.9–31.2)
Preoperative TNM staging
T3N0M0 8
T3N1M0 9
T3N2M0 2
T3N3M1 1
ISR
Partial/subtotal/total 15/1/4
Median duration of TARD (min) 83 (43–135)
Male 89 (50–135)
Female 81 (43–97)
Postoperative TNM staging
ypT2N0M0 1
ypT3N0M0 1
pT2N0M0 4
pT2N1M0 2
pT3N0M0 7
pT3N1M0 2
pT3N2M0 2
pT3N2M1 1
Median tumor size (mm) 42 (15–75)
Median circumferential rate of tumor (%) 66 (27.7–90)
Median distal margin (mm) 22.5 (7–40)
ISR: intersphincteric resection.
ensure that the subsequent coloanal anastomosis is free
of tension. The sigmoid colon and its mesentery are then
removed, the lymph nodes around the inferior mesenteric
artery are dissected with a harmonic scalpel, and the inferior
mesenteric artery is ligated at a high level with an endoclip.
It is relatively easy to dissect Denonvillier’s fascia and expose
the seminal vesicles and prostate gland or the posterior wall
of the vagina on the anterior side and to mobilize the lower
rectum and mesorectum from the sacrum on the separated
plane between the visceral and parietal endopelvic fascia
through the anus. The lateral ligaments of the rectum are
gradually divided with a harmonic scalpel from the inner
limit of the inferior hypogastric nerve ﬁbers, and the rectum,
including the total mesorectum, is completely removed from
the pelvic ﬂoor. The colon and rectum are pulled out of the
umbilical wound and are resected. A coloanal anastomosis is
transanally performed by hand suturing. Finally, a diverting
ileostomyiscreated.Thedivertingileostomyisreversedthree
to six months after surgery (Figure 2).
3.1.FunctionalAssessment. Sphincterfunctionwasevaluated
clinically in 3, 6, and 12 months after stoma closure. The
patients were questioned about frequency of bowel move-
ments, ability to defer defecation for 15 minutes (urgency),
and satisfaction of defecation status using visual analogueInternational Journal of Surgical Oncology 3
(a) (b)
(c)
Figure 1: Transanal rectal dissection for a male patient with T3 low rectal cancer. A circular incision of the rectum was performed by closing
the cut end of the rectum (a). The rectum including the tumor was mobilized proximally by exposing the levator ani (b, c).
scale (VAS). Continence status was determined according to
the classiﬁcation of Wexner incontinence score (WIS).
4. Results
The numbers of patients undergoing partial, subtotal, and
total ISR were 15, 1, and 4, respectively. There was no
conversion to an open operation. The median duration of
TARD procedure was 83min (range 43–135min) and was
longer in males than in females (81min versus 89min).
Although there were no major complications perioperatively
orpostoperatively,anastomoticstenosisintwomalepatients,
bowel obstruction in one male patient, and pelvic abscess
formation in one female patient occurred postoperatively.
Morphologically, the median maximum tumor size was
42mm (15–75mm), and the median circumferential rate
of tumor was 66% (27.7–90.0%). The average distance
from the rectal stump was 16mm (range 7–40mm), and
circumferential and distal margins were histologically free
of tumor cells in all patients. Pathological response grading
following preoperative CRT performed for two patients was
grade 2 and grade 1b, respectively. Finally, postoperative
pathological staging was ypT2N0M0 in one, ypT3N0M0
in one, pT2N0M0 in 4, pT2N1M0 in 2, pT3N0M0 in 7,
pT3N1M0 in 2, pT3N2M0 in 2, and pT3N2M1 in one
patient. The median number of evaluated lymph nodes was
12.5 nodes. Distant organ metastasis developed in 2 patients,
but there was no local recurrence.
Eighteen out of 20 patients received stoma closure
excluding one with distant metastasis and one who did not
want stoma closure. In this study sphincter function was
investigated for twelve out of 18 patients in 3, 6, and 12
months after stoma closure. Half ten patients, experienced
nine and more bowel movements a day, 8 (80%) complained
urgency, and 8 (80%) reported ﬁve or less VAS in three
months after stoma closure. In twelve months after stoma
closure, the rate of the patients who experienced nine and
more bowel movements a day and reported ﬁve or less VAS
decreased to 20% and 17%, respectively, but nine (75%)
complained urgency. Regarding continence status, the rate
of the patients answered ten and more WIS in three months
and twelve months after stoma closure were 50% and 33%,
respectively (Table 2).
5. Discussion
ISR has been shown to preserve anal sphincter function
and provide an adequate oncologic resection for low rectal
cancers since Schiessel’s ﬁrst report in 1994. The pooled
rate of local recurrence was 0–31%, with an average 5-
year survival of 81.5%, in an evaluation of the experience
of 13 centers and 612 patients by Tilney and Tekkis [2].4 International Journal of Surgical Oncology
(a) (b)
(c) (d)
Figure 2:Laparoscopicprocedurecombinedwithtransanalrectaldissection.Thegauzethatwasplacedonthedissectedplaneasalandmark
was able to be identiﬁed through the peritoneum on the anterior side on the rectum. It was relatively easy to dissect Denonvillier’s fascia
and expose the seminal vesicles and prostate gland (a). On the posterior side of the rectum, it was possible to mobilize the lower rectum and
mesorectum from the sacrum on the separated plane between the visceral and parietal endopelvic fascia through the anus (b). The lateral
ligaments of the rectum were gradually divided with a harmonic scalpel from the inner limit of the inferior hypogastric nerve ﬁbers. The
rectum, including the total mesorectum, was completely removed from the pelvic ﬂoor (c, d).
Table 2: Sphincter function after stoma closure.
3m o n t h s( n = 10)
No. of patients (%)
6m o n t h s( n = 10)
No. of patients (%)
12 months (n = 12)
No. of patients (%)
Urgency 8 (80) 8 (80) 9 (75)
Frequency of bowel movements
≤3 1 (10) 3 (30) 3 (30)
4-5 3 (30) 3 (30) 6 (60)
6–8 0 1 (10) 1 (10)
≥9 5 (50) 3 (30) 2 (20)
VAS
<5 8 (80) 4 (40) 2 (17)
5–7 1 (10) 3 (30) 3 (25)
≥7 1 (10) 3 (30) 7 (58)
WIS <10 5 (50) 6 (60) 8 (67)
≥10 5 (50) 4 (40) 4 (33)
VAS: visual analogue scale, WIS: Wexners’ incontinence score.
Recently,clinical outcomes of ISR as a laparoscopic approach
have been reported, but laparoscopic ISR for bulky low
rectal cancer is challenging, especially for T3 low rectal
cancer in patients with a narrow pelvis. Laurent et al. [6]
made a comparison between 110 patients undergoing the
laparoscopic approach and 65 patients undergoing an open
approach and reported a satisfactory outcome of laparo-
scopic ISR, with a 5-year disease-free survival of 70% and a
5-year local recurrence of 5%. Fujimoto et al. [7] also noted
the advantages of laparoscopic ISR in their evaluation ofInternational Journal of Surgical Oncology 5
35 patients with low rectal cancer. However, in these reports
the inﬂuence of narrow pelvic dimensions on outcomes of
laparoscopic ISR was not described. Also, Akasu et al. [8]
r e p o r t e dt h a tl o c a lc o n t r o lf o rT 3t u m o r sw a sd i ﬃcult as
compared with T1-T2 tumors. In our study, only patients
with T3 low rectal cancer and a narrow pelvis were included
in the analysis. With consideration of a good oncologic
outcome with a low recurrence rate after surgery for T3
low rectal cancer, some prerequisites are necessary regardless
o ft h eI S Ra p p r o a c h :T M E ,n e g a t i v eC F M ,a n dt u m o r - f r e e
surgical margins. In most prior studies, pathological TNM
stage and T stage were reported as important risk factors
for prognosis. In addition, Akasu et al. [9] reported that
the resection margin, focal diﬀerentiation, and serum CA
19-9 level were important risk factors of local recurrence
in an evaluation of 120 patients with very low rectal cancer
including 46 patients with stage III disease. In this study,
preoperative radiographic examination demonstrated bulky
tumor occupying the pelvis in all patients. Although preop-
erative CRT in order to decrease the volume of tumor and
prevent local recurrence was performed only for two patients
secondary to preference, the resection margin including the
radial margin was histologically free of tumor in all patients
including patients without preoperative CRT. Conversion to
open operation impacted signiﬁcantly on overall survival
exceptwhenconsideringlong-termdisease-freesurvivalwith
laparoscopic surgery for colorectal cancer [4]. This subject
deserves more than a passing notice, and conversion to open
operation should be avoided to prevent local recurrence
in laparoscopic ISR as well. In general, the following risk
factors for conversion to open operation from traditional
laparoscopic surgery for rectal cancer were reported: obesity,
bulky tumor, and bony pelvis. In laparoscopic ISR, these
factors may make laparoscopically assisted pelvic dissection
even more challenging because these factors further conﬁne
the surgical ﬁeld, hindering visualization and retraction in
a deep and narrow pelvis. Tekkis et al. [10] and Scheidbach
et al. [11] reported a direct correlation between increasing
bodymassindexandhigherconversionratesforlaparoscopic
colorectal surgery. B` ege et al. [12] and Yamamoto et al.
[13] conﬁrmed the correlation between body mass index
and conversion rate. In this study, laparoscopic ISR without
conversion to open operation was achieved for all patients,
with a median body mass index of 25.3kg/m2 and a median
tumor circumferential rate of 66%.
In general, transanal manipulation for dissection of
the tumor from the levator ani and external sphincter is
performed after the abdominal phase of ISR, including
the procedure described by Schiesel. On the other hand,
Teramoto et al. [14] and Watanabe et al. [15] introduced per
anum intersphincteric rectal dissection with direct coloanal
anastomosis (PIDCA), a surgical technique for low rectal
cancer performed before the abdominal phase. However,
long-term outcomes with local recurrence at 31% were not
satisfactory, the reasons for which are unclear [16]. Although
Uchikoshi et al. [17] reported good clinical results with
laparoscopic ISR combined with transanal manipulation
prior to the abdominal phase for two patients with T2
very low rectal cancer and total colectomy for two patients
with ulcerative colitis complicated by T1 colorectal cancer;
feasibility for T3 low rectal cancer could not be evaluated
due to the small number of patients. We also consider
that TARD as the transanal procedure performed prior
to the laparoscopically assisted abdominal phase is very
useful to achieve a good oncologic result with a low local
recurrence, when performed with laparoscopic ISR for bulky
low rectal cancer, especially T3 low rectal cancer in patients
with a narrow pelvis. In fact, we experienced neither major
complication nor conversion to open operation in this study.
For T3 tumors, a high local recurrence rate in patients
without radiotherapy was reported by Tekkis et al. [10],
but there was no local recurrence in selective patients
with a narrow pelvis. However, this study was retrospective
and limited by a short postoperative observation period
(median 23.6 months). Exclusion of patients with T4 tumors
with TAUS preoperatively may decrease local recurrence. In
addition, TARD was able to dissect with adequate radial
margins around the tumor under direct vision even if the
tumor invaded near the levator ani and was considered to
be eﬀective for a good oncologic outcome. In this study,
preoperative CRT decreased the volume of the primary
tumorinonepatientallowingforlaparoscopicISR.However,
the other patient had Grade 1b cancer, and preoperative
CRT was not considered to be eﬀective for laparoscopically
assisted pelvic ﬂoor dissection. While some researchers have
reported a good correlation between the volume reduction
rate of primary tumor and pathologic tumor response of
preoperative CRT [18, 19], complete pathological response
r a t ew a sr e p o r t e dt ob eo n l yf r o m7 %t o3 4 . 7 %[ 20–22]. For
some of the nonresponders, a histological reaction (ﬁbrosis
and/or edema) may have occurred in the rectum itself, and
adjacent organs may have made pelvic dissection around the
tumor more diﬃcult.
Sphincter function after ISR impacts on quality of life
of patients signiﬁcantly. In this study, sphincter function
was investigated for limited patients in 3, 6, and 12 months
afterstomaclosure.FrequencyofbowelmovementsandWIS
improved gradually, but the fact that 75% of the patients
complained urgency in 12 months after stoma closure can
hardly be ignored. Although preoperative radiation therapy,
volume of resected internal sphincter muscle, or gender was
reportedaspoorriskfactorsofsphinctericdysfunction,these
results could not be explained by these factors in this study
[23–26].
In conclusion laparoscopic ISR will be widely adopted as
an acceptable procedure to preserve anal sphincter function
for low rectal cancer extending to the anal canal. Laparo-
scopic ISR combined with TARD is technically possible for
selectiveT3lowbulkyrectalcancer,andasatisfactoryclinical
outcome was achieved in this series.
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